AI assistance in kidney disease diagnosis
National Kidney Action Week, observed from 11 - 17 May, serves as a crucial reminder that diabetes is the leading cause of end-stage kidney disease. ACADI’s latest innovation, RenoTrue™, aims to aid in kidney disease prevention by enabling earlier detection of kidney function decline.
RenoTrue™ logo.
Unlike traditional screening methods, the RenoTrue™ algorithm is tailored for individuals with diabetes, providing more precise kidney function estimates. With its recent trademark registration, RenoTrue™ is poised to provide people living with all types of diabetes the opportunity for a healthier future.
Find out more about RenoTrue™ at ACADI’s 24 May Seminar, featuring ACADI Director Professor Elif Ekinci and PhD student Rodney Kwok.